{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:26:44Z","timestamp":1793327204586,"version":"4.5.0"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM088558"],"award-info":[{"award-number":["U54GM088558"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We searched the PubMed database for clinical trials and observational human studies about postexposure vaccination effects, targeting infections with approved vaccines and vaccines licensed outside the United States against dengue, hepatitis E, malaria, and tick-borne encephalitis. Studies of animal models, serologic testing, and pipeline vaccines were excluded. Eligible studies were evaluated by definition of exposure; attempts to distinguish pre- and postexposure effects were rated on a scale of 1 to 4. We screened 4,518 articles and ultimately identified for this review 14 clinical trials and 31 observational studies spanning 7 of the 28 vaccine-preventable diseases. For secondary attack rate, the following medians were found for postexposure vaccination effectiveness: hepatitis A, 85% (interquartile range (IQR), 28; n\u00a0=\u00a05 sources); hepatitis B, 85% (IQR, 22; n\u00a0=\u00a05 sources); measles, 83% (IQR, 21; n\u00a0=\u00a08 sources); varicella, 67% (IQR: 48; n\u00a0=\u00a09 sources); smallpox, 45% (IQR, 39; n\u00a0=\u00a04 sources); and mumps, 38% (IQR, 7; n\u00a0=\u00a02 sources). For case fatality proportions resulting from rabies and smallpox, the median vaccine postexposure efficacies were 100% (IQR, 0; n\u00a0=\u00a06 sources) and 63% (IQR, 50; n\u00a0=\u00a08 sources), respectively. Many available vaccines can modify or preclude disease if administered after exposure. This postexposure effectiveness could be important to consider during vaccine trials and while developing new vaccines.<\/jats:p>","DOI":"10.1093\/epirev\/mxz014","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T15:16:33Z","timestamp":1571930193000},"page":"13-27","source":"Crossref","is-referenced-by-count":35,"title":["Postexposure Effects of Vaccines on Infectious Diseases"],"prefix":"10.1093","volume":"41","author":[{"given":"Tara","family":"Gallagher","sequence":"first","affiliation":[{"name":"Dartmouth College Department of Physics and Astronomy, Hanover, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lipsitch","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"2021052713042912200_ref1","volume-title":"Plotkin\u2019s Vaccines. 7th ed","author":"Plotkin","year":"2017"},{"issue":"suppl 2","key":"2021052713042912200_ref2","doi-asserted-by":"crossref","first-page":"14559","DOI":"10.1073\/pnas.0405924101","article-title":"Therapeutic vaccines: realities of today and hopes for tomorrow","volume":"10","author":"Sela","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"2021052713042912200_ref3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1086\/374054","article-title":"Can postexposure vaccination against smallpox succeed?","volume":"36","author":"Henderson","year":"2003","journal-title":"Clin Infect Dis."},{"issue":"7","key":"2021052713042912200_ref4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1086\/378357","article-title":"Effectiveness of postexposure vaccination for the prevention of smallpox: results of a Delphi analysis","volume":"188","author":"Massoudi","year":"2003","journal-title":"J Infect Dis."},{"issue":"1","key":"2021052713042912200_ref5","article-title":"Challenges and achievements in prevention and treatment of smallpox","volume":"6","author":"Melamed","year":"2018","journal-title":"Vaccines (Basel)."},{"issue":"1","key":"2021052713042912200_ref6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog."},{"issue":"10","key":"2021052713042912200_ref7","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1086\/324087","article-title":"Failure of multiple-site intradermal post-exposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts","volume":"33","author":"Tantawichien","year":"2001","journal-title":"Clin Infect Dis."},{"issue":"9","key":"2021052713042912200_ref8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3201\/eid1009.030921","article-title":"Potential public health impact of new tuberculosis vaccines","volume":"10","author":"Ziv","year":"2004","journal-title":"Emerg Infect Dis."},{"issue":"17","key":"2021052713042912200_ref9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med."},{"issue":"1","key":"2021052713042912200_ref10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.105.1.84","article-title":"Postexposure effectiveness of varicella vaccine","volume":"105","author":"Watson","year":"2000","journal-title":"Pediatrics."},{"key":"2021052713042912200_ref11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijid.2017.10.016","article-title":"Effectiveness of varicella vaccine as post-exposure prophylaxis during a varicella outbreak in Shanghai, China","volume":"66","author":"Wu","year":"2018","journal-title":"Int J Infect Dis."},{"issue":"7","key":"2021052713042912200_ref12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199208133270702","article-title":"A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children","volume":"327","author":"Werzberger","year":"1992","journal-title":"N Engl J Med."},{"issue":"9159","key":"2021052713042912200_ref13","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(98)08139-2","article-title":"Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial","volume":"353","author":"Sagliocca","year":"1999","journal-title":"Lancet."},{"key":"2021052713042912200_ref14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM196307112690204","article-title":"Use of live-measles-virus vaccine to abort an expected outbreak of measles within a closed population","volume":"269","author":"Berkovich","year":"1963","journal-title":"N Engl J Med."},{"issue":"11","key":"2021052713042912200_ref15","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/cid\/cix639","article-title":"Effectiveness of measles vaccination and immune globulin post-exposure prophylaxis in an outbreak setting\u2014New York City, 2013","volume":"65","author":"Arciuolo","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2021052713042912200_ref16","first-page":"3","article-title":"Protection against varicella in family contacts by immediate inoculation with live varicella vaccine","volume":"59","author":"Asano","year":"1977","journal-title":"Pediatrics."},{"issue":"1","key":"2021052713042912200_ref17","first-page":"43","article-title":"Protective effect of immediate inoculation of a live varicella vaccine in household contacts in relation to the viral dose and interval between exposure and vaccination","volume":"25","author":"Asano","year":"1982","journal-title":"Biken J."},{"issue":"4","key":"2021052713042912200_ref18","first-page":"742","article-title":"Varicella vaccine studies in healthy children and adults","volume":"78","author":"Arbeter","year":"1986","journal-title":"Pediatrics."},{"issue":"3","key":"2021052713042912200_ref19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00006454-199803000-00020","article-title":"Postexposure varicella vaccination in siblings of children with active varicella","volume":"17","author":"Salzman","year":"1998","journal-title":"Pediatr Infect Dis J."},{"issue":"3","key":"2021052713042912200_ref20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.vaccine.2004.06.004","article-title":"Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting\u2014a pilot study","volume":"23","author":"Mor","year":"2004","journal-title":"Vaccine."},{"issue":"1","key":"2021052713042912200_ref21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/INF.0b013e3181b36022","article-title":"Effectiveness of varicella vaccines as postexposure prophylaxis","volume":"29","author":"Brotons","year":"2010","journal-title":"Pediatr Infect Dis J."},{"issue":"11\u201312","key":"2021052713042912200_ref22","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/00365548.2010.511259","article-title":"Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measures","volume":"43","author":"G\u00e9taz","year":"2010","journal-title":"Scand J Infect Dis."},{"issue":"17","key":"2021052713042912200_ref23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa070546","article-title":"Hepatitis A vaccine versus immune globulin for postexposure prophylaxis","volume":"357","author":"Victor","year":"2007","journal-title":"N Engl J Med."},{"issue":"10","key":"2021052713042912200_ref24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078914","article-title":"Evaluation of hepatitis A vaccine in post-exposure prophylaxis, the Netherlands, 2004\u20132012","volume":"8","author":"Whelan","year":"2013","journal-title":"PLoS One."},{"issue":"2","key":"2021052713042912200_ref25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/21645515.2017.1264798","article-title":"Effectiveness of hepatitis A vaccination as post-exposure prophylaxis","volume":"13","author":"Parr\u00f3n","year":"2017","journal-title":"Hum Vaccin Immunother."},{"issue":"15","key":"2021052713042912200_ref26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States","volume":"303","author":"Szmuness","year":"1980","journal-title":"N Engl J Med."},{"issue":"8359","key":"2021052713042912200_ref27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine","volume":"322","author":"Beasley","year":"1983","journal-title":"Lancet."},{"issue":"1","key":"2021052713042912200_ref28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0264-410X(85)90007-6","article-title":"Post-exposure active immunoprophylaxis of spouses of acute viral hepatitis B patients","volume":"3","author":"Roumeliotou-Karayannis","year":"1985","journal-title":"Vaccine."},{"issue":"8635","key":"2021052713042912200_ref29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(89)90003-2","article-title":"Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA","volume":"1","author":"Ip","year":"1989","journal-title":"Lancet."},{"issue":"1","key":"2021052713042912200_ref30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/infdis\/171.1.54","article-title":"Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection","volume":"171","author":"Xu","year":"1995","journal-title":"J Infect Dis."},{"issue":"5334","key":"2021052713042912200_ref31","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/bmj.1.5334.860","article-title":"Protection after exposure to measles by attenuated vaccine without gamma-globulin","volume":"1","author":"Watson","year":"1963","journal-title":"Br Med J."},{"issue":"1","key":"2021052713042912200_ref32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3476(78)80597-6","article-title":"Measles vaccination after exposure to natural measles","volume":"93","author":"Ruuskanen","year":"1978","journal-title":"J Pediatr."},{"issue":"5\u20136","key":"2021052713042912200_ref33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1071\/NB08014","article-title":"The effectiveness of prophylaxis for measles contacts in NSW","volume":"20","author":"Sheppeard","year":"2009","journal-title":"N S W Public Health Bull."},{"issue":"1","key":"2021052713042912200_ref34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/INF.0b013e3181f7001c","article-title":"Effectiveness of measles vaccination for control of exposed children","volume":"30","author":"Barrabeig","year":"2011","journal-title":"Pediatr Infect Dis J."},{"issue":"6","key":"2021052713042912200_ref35","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/infdis\/158.6.1253","article-title":"A large outbreak of mumps in the postvaccine era","volume":"158","author":"Wharton","year":"1988","journal-title":"J Infect Dis."},{"issue":"9","key":"2021052713042912200_ref36","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3201\/eid1909.130299","article-title":"Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA","volume":"19","author":"Fiebelkorn","year":"2013","journal-title":"Emerg Infect Dis."},{"issue":"24","key":"2021052713042912200_ref37","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1001\/jama.1976.03270250019017","article-title":"Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum","volume":"236","author":"Bahmanyar","year":"1976","journal-title":"JAMA."},{"issue":"2","key":"2021052713042912200_ref38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/infdis\/142.2.133","article-title":"Postexposure trial of a human diploid cell strain rabies vaccine","volume":"142","author":"Anderson","year":"1980","journal-title":"J Infect Dis."},{"issue":"15","key":"2021052713042912200_ref39","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jama.1983.03340150032022","article-title":"The epidemiology of human rabies postexposure prophylaxis, 1980\u20131981","volume":"250","author":"Helmick","year":"1983","journal-title":"JAMA."},{"issue":"6","key":"2021052713042912200_ref40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0264-410X(94)00049-S","article-title":"Efficacy study of a new albumin-free human diploid cell rabies vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patients","volume":"13","author":"Wilde","year":"1995","journal-title":"Vaccine."},{"issue":"2","key":"2021052713042912200_ref41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinids\/22.2.228","article-title":"Failure of postexposure treatment of rabies in children","volume":"22","author":"Wilde","year":"1996","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2021052713042912200_ref42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0001-706X(99)00092-3","article-title":"Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines","volume":"75","author":"Quiambao","year":"2000","journal-title":"Acta Trop."},{"key":"2021052713042912200_ref43","first-page":"July 5:40","article-title":"Small-pox in Glasgow, 1900-02","author":"McVail","year":"1902","journal-title":"Br Med J."},{"issue":"4","key":"2021052713042912200_ref44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/rmv.361","article-title":"Studies in smallpox and vaccination. 1913","volume":"12","author":"Hanna","year":"2002","journal-title":"Rev Med Virol."},{"issue":"5","key":"2021052713042912200_ref45","first-page":"227","article-title":"Some aspects of the epidemiology of smallpox in Scotland in 1942","volume":"36","author":"Sutherland","year":"1943","journal-title":"Proc R Soc Med."},{"issue":"4","key":"2021052713042912200_ref46","first-page":"351","article-title":"Smallpox in Tripolitania, 1946: an epidemiological and clinical study of 500 cases, including trials of penicillin treatment","volume":"46","author":"Dixon","year":"1948","journal-title":"J Hyg (Lond)."},{"key":"2021052713042912200_ref47","volume-title":"Smallpox","author":"Rao"},{"issue":"5278","key":"2021052713042912200_ref48","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.1.5278.612","article-title":"Smallpox in Bradford, 1962","volume":"1","author":"Douglas","year":"1962","journal-title":"Br Med J."},{"issue":"4","key":"2021052713042912200_ref49","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/oxfordjournals.aje.a121326","article-title":"A study of Intrafamilial transmission of smallpox","volume":"94","author":"Heiner","year":"1971","journal-title":"Am J Epidemiol."},{"issue":"2","key":"2021052713042912200_ref50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/oxfordjournals.aje.a121380","article-title":"Epidemiology of smallpox in West Pakistan: I. Acquired immunity and the distribution of disease","volume":"95","author":"Mack","year":"1972","journal-title":"Am J Epidemiol."},{"issue":"2","key":"2021052713042912200_ref51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/infdis\/125.2.161","article-title":"Smallpox in Europe, 1950\u20131971","volume":"125","author":"Mack","year":"1972","journal-title":"J Infect Dis."},{"issue":"4","key":"2021052713042912200_ref52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/oxfordjournals.aje.a121615","article-title":"The 1972 smallpox outbreak in Kuhlna municipality, Bangladesh: II. Effectiveness of surveillance and containment in urban epidemic control","volume":"99","author":"Sommer","year":"1974","journal-title":"Am J Epidemiol."},{"issue":"3","key":"2021052713042912200_ref53","first-page":"301","article-title":"Clinical observations on smallpox: a study of 1233 patients admitted to the infectious diseases hospital, Calcutta, during 1973","volume":"52","author":"Mazumder","year":"1975","journal-title":"Bull World Health Organ."},{"issue":"45","key":"2021052713042912200_ref54","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1016\/j.vaccine.2013.08.039","article-title":"The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data","volume":"31","author":"Keckler","year":"2013","journal-title":"Vaccine."},{"issue":"1\u20132","key":"2021052713042912200_ref55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijheh.2007.01.029","article-title":"Interpreting the epidemiology of postexposure vaccination against smallpox","volume":"211","author":"Nishiura","year":"2008","journal-title":"Int J Environ Health."},{"issue":"7537","key":"2021052713042912200_ref56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/bmj.38719.435833.7C","article-title":"Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis","volume":"332","author":"Lee","year":"2006","journal-title":"BMJ."},{"issue":"20","key":"2021052713042912200_ref57","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1016\/j.vaccine.2018.04.015","article-title":"Use of hepatitis a vaccine for post-exposure prophylaxis in individuals over 40 years of age: a systematic review of published studies and recommendations for vaccine use","volume":"36","author":"Link-Gelles","year":"2018","journal-title":"Vaccine."},{"key":"2021052713042912200_ref58","first-page":"CD001833","article-title":"Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults","volume":"6","author":"Macartney","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"2021052713042912200_ref59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2310\/7060.2002.23219","article-title":"Risk of possible exposure to rabies among tourists and foreign residents in Nepal","volume":"9","author":"Pandey","year":"2002","journal-title":"J Travel Med."},{"key":"2021052713042912200_ref60","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N Engl J Med."},{"issue":"8","key":"2021052713042912200_ref61","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J."},{"issue":"1","key":"2021052713042912200_ref62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.idcr.2014.11.003","article-title":"The importance of tetanus risk assessment during wound management","volume":"2","author":"Collins","year":"2015","journal-title":"IDCases."},{"issue":"3","key":"2021052713042912200_ref63","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/cid\/ciw025","article-title":"BCG and new preventive tuberculosis vaccines: implications for healthcare workers","volume":"62","author":"Hatherill","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"2","key":"2021052713042912200_ref64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med."},{"issue":"2","key":"2021052713042912200_ref65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14712598.2018.1404572","article-title":"From bench to almost bedside: the long road to a licensed Ebola virus vaccine","volume":"18","author":"Wong","year":"2018","journal-title":"Expert Opin Biol Ther."},{"issue":"12","key":"2021052713042912200_ref66","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.2015.1995","article-title":"Emergency postexposure vaccination with vesicular stomatitis virus\u2013vectored Ebola vaccine after needlestick","volume":"313","author":"Lai","year":"2015","journal-title":"JAMA."},{"issue":"6","key":"2021052713042912200_ref67","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S1473-3099(17)30677-1","article-title":"Ebola virus disease: an update on post-exposure prophylaxis","volume":"18","author":"Fischer","year":"2018","journal-title":"Lancet."},{"issue":"6","key":"2021052713042912200_ref68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrd.2017.251","article-title":"Post-exposure treatments for Ebola and Marburg virus infections","volume":"17","author":"Cross","year":"2018","journal-title":"Nat Rev Drug Discov."},{"issue":"7","key":"2021052713042912200_ref69","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infec Dis."},{"issue":"11","key":"2021052713042912200_ref70","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med."},{"issue":"29","key":"2021052713042912200_ref71","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.vaccine.2009.04.009","article-title":"Estimation of vaccine efficacy against acquisition of pneumococcal carriage","volume":"27","author":"Rinta-Kokko","year":"2009","journal-title":"Vaccine."},{"issue":"10068","key":"2021052713042912200_ref72","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet."},{"issue":"1","key":"2021052713042912200_ref73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2011.281","article-title":"Vaccines for drug abuse","volume":"91","author":"Shen","year":"2012","journal-title":"Clin Pharmacol Ther."},{"issue":"1","key":"2021052713042912200_ref74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrd1284","article-title":"Therapeutic vaccination for chronic diseases: a new class of drugs in sight","volume":"3","author":"Bachmann","year":"2004","journal-title":"Nat Rev Drug Discov."},{"issue":"84","key":"2021052713042912200_ref75","first-page":"319","article-title":"Advances in the development of vaccines for Alzheimer's disease","volume":"15","author":"Lambracht-Washington","year":"2013","journal-title":"Discov Med."},{"issue":"8","key":"2021052713042912200_ref76","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/14760584.2018.1500905","article-title":"Recent advancements toward therapeutic vaccines against Alzheimer\u2019s disease","volume":"17","author":"Herline","year":"2018","journal-title":"Expert Rev Vaccines."},{"key":"2021052713042912200_ref77","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.coviro.2016.02.010","article-title":"Approaches to preventative and therapeutic HIV vaccines","volume":"17","author":"Gray","year":"2016","journal-title":"Curr Opin Virol."},{"issue":"suppl 18","key":"2021052713042912200_ref78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1200\/jco.2009.27.15_suppl.2","article-title":"Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: phase III clinical trial results","volume":"27","author":"Schuster","year":"2009","journal-title":"J Clin Oncol."},{"issue":"suppl","key":"2021052713042912200_ref79","first-page":"463S","article-title":"A phase III multi-institutional randomized study of immunization with the gp100: 209\u2013217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma","volume":"27","author":"Schwartzentruber","year":"2009","journal-title":"J Clin Oncol."},{"issue":"1","key":"2021052713042912200_ref80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.2010.00979.x","article-title":"Therapeutic cancer vaccines: are we there yet?","volume":"239","author":"Klebanoff","year":"2011","journal-title":"Immunol Rev."},{"issue":"11","key":"2021052713042912200_ref81","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-10-3126","article-title":"Provenge (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine","volume":"17","author":"Cheever","year":"2011","journal-title":"Clin Cancer Res."},{"issue":"8","key":"2021052713042912200_ref82","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jamadermatol.2018.1748","article-title":"Combined systemic and intratumoral administration of human papillomavirus vaccine to treat multiple cutaneous basaloid squamous cell carcinomas","volume":"154","author":"Nichols","year":"2018","journal-title":"JAMA Dermatol."},{"key":"2021052713042912200_ref83","author":"US Centers for Disease Control and Prevention"},{"key":"2021052713042912200_ref84","volume-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","author":"Hamborsky","year":"2015","edition":"13th"},{"key":"2021052713042912200_ref85","author":"US Centers for Disease Control and Prevention"}],"container-title":["Epidemiologic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/epirev\/advance-article-pdf\/doi\/10.1093\/epirev\/mxz014\/30339157\/mxz014.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/epirev\/article-pdf\/41\/1\/13\/38324609\/epirev_41_1_13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/epirev\/article-pdf\/41\/1\/13\/38324609\/epirev_41_1_13.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T14:01:36Z","timestamp":1622124096000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/epirev\/article\/41\/1\/13\/5610787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,11,4]]},"published-print":{"date-parts":[[2019,1,31]]}},"URL":"https:\/\/doi.org\/10.1093\/epirev\/mxz014","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/19001396","asserted-by":"object"}]},"ISSN":["1478-6729"],"issn-type":[{"value":"1478-6729","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019]]},"published":{"date-parts":[[2019]]}}}